BNGO - Bionano Genomics Net loss of $32.16M revenue of $6.67M beats by $0.39M
- Bionano Genomics press release ( NASDAQ: BNGO ): Q2 Net loss of $32.16M.
- Revenue of $6.67M (+72.8% Y/Y) beats by $0.39M .
- Gross margin for Q2 2022 was 22%, compared to 37% from Q2 2021
- At June 30, 2022, the Company had cash, cash equivalents, and available-for-sale securities of $187.3 million.
- Shares -6.38% .
For further details see:
Bionano Genomics Net loss of $32.16M, revenue of $6.67M beats by $0.39M